Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Helene Blons Gunnar Folprecht Josep Tabernero Caturla Pierre Laurent-Puig Aziz Zaanan |
| Publication date | May 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |